Moshe Yeshurun

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity

Avichai Shimoni, Izhar Hardan, Noga Shem‐Tov et al. · Leukemia · 2005 · 311 citations

Cell Therapy, Transplantation, Marrow Transplantation +9

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

Mohamed A. Kharfan‐Dabaja, Myriam Labopin, Emmanuelle Polge et al. · JAMA Oncology · 2018 · 164 citations · Full text

Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).

Igor Resnick, Claudine Barkats, Michael Y. Shapira et al. · PubMed · 2013 · 118 citations · Full text

A randomized study comparing yttrium‐90 ibritumomab tiuxetan (Zevalin) and high‐dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma

Avichai Shimoni, Irit Avivi, Jacob M. Rowe et al. · Cancer · 2012 · 107 citations

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

Avichai Shimoni, Nicolaus Kröger, Tatjana Zabelina et al. · Leukemia · 2004 · 99 citations

Unrelated Donors, Transplantation, Marrow Transplantation +11